Semagacestat
-
Catalog number2430-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name(S)-2-hydroxy-3-methyl-N-((S)-1-((S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ylamino)-1-oxopropan-2-yl)butanamide ; LY450139
-
DescriptionA potent γ-secretase inhibitor (IC₅₀ = 10.9 nM, 12.1 nM and 12.0 nM for Aβ42, Aβ40 and Aβ38, respectively). Semagacestat has shown to reduce the rate of formation of amyloid-β in vitro and in vivo.
-
CAS Number425386-60-3
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₉H₂₇N₃O₄
-
Molecular Weight361.44
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>60 mg/ml) or EtOH (>40 mg/ml)
-
HandlingProtect from light and air
-
Tag LineA potent γ-secretase inhibitor
-
Storage Condition-20 ̊C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID9843750
-
SMILESCC(C)C(C(=O)NC(C)C(=O)NC1C2=CC=CC=C2CCN(C1=O)C)O
-
InChiInChI=1S/C19H27N3O4/c1-11(2)16(23)18(25)20-12(3)17(24)21-15-14-8-6-5-7-13(14)9-10-22(4)19(15)26/h5-8,11-12,15-16,23H,9-10H2,1-4H3,(H,20,25)(H,21,24)/t12-,15-,16-/m0/s1
-
InChi KeyPKXWXXPNHIWQHW-RCBQFDQVSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameSemagacestat
-
Alternative nameSemagacestat
-